About Us

Empowered by AI,
Designed for Humanity.

AI x HUMAN-RELEVANT BIOLOGY

Human-Centered AI for
Drug Discovery

Combines AI with human-relevant biology to accelerate drug discovery—grounded in ethics, usability, and real-world impact.

AI-POWERED

Microphysiological Platform

Organ-on-chip + AI agents to deliver faster, more reliable preclinical insights.

3RS PRINCIPLE

Replace, Reduce,
and Refine

Driven by the 3Rs, our global team is redefining drug development with scalable, animal-free solutions.

MEET THE FOUNDER

Guan Yu Chen, Ph.D.Founder & CEO

“

No Animals, No Delays, Just Human Data'
is the future we envision.'No Animals, No Delays,
Just Human Data'
is the future we envision.

Dr. Guan-Yu Chen is the Founder and CEO of Anivance AI, a biotechnology company building physical AI infrastructure for human biology through organ-on-chip systems, laboratory automation, and AI-driven biomedical analysis.

Spun out from National Yang Ming Chiao Tung University (NYCU), the company builds on more than a decade of Dr. Chen's research in organ-on-chip technologies and bioengineering.

50+Publications

30+Research Programs

25+International Patents

Selected Honors